GlassScriptPhysician profile
Britta L Buchenroth
NPI 1962744045
$1,384.43
in general payments reported to CMS, 2019-2025
20 companies · $125 in 2025
The $125 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $443 · 2020: $130 · 2021: $164 · 2022: $125 · 2023: $275 · 2024: $122 · 2025: $125.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $522.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $522.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $387.80 | 2019-2022 | |
| Myovant Sciences INC. | $189.80 | 2021-2022 | |
| Astellas Pharma US INC | $180.17 | 2023-2025 | Veozah |
| Coopersurgical, INC. | $131.66 | 2019-2024 | Paragard T 380a |
| Hologic Sales and Service, LLC | $79.53 | 2020-2025 | Acessa Provu System, Aptima, Novasure |
| Bayer Healthcare Pharmaceuticals INC. | $60.64 | 2022-2024 | |
| Mayne Pharma Commercial LLC | $53.33 | 2023-2024 | |
| Organon LLC | $45.79 | 2022-2024 | |
| Biogen, INC. | $40.35 | 2025 | Zurzuvae |
| Minerva Surgical, INC | $29.00 | 2019-2023 | |
| Therapeuticsmd, INC. | $27.53 | 2019 | |
| Lupin INC. | $27.00 | 2019 | |
| Dexcom, INC. | $23.72 | 2023 | Dexcom G6 Transmitter |
| Agile Therapeutics, INC. | $20.62 | 2023 | Twirla |
| Sumitomo Pharma America, INC. | $20.15 | 2023 | Myfembree |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shield Therapeutics INC | $16.01 | 2025 | |
| Glaxosmithkline, LLC. | $14.66 | 2019 | |
| Allergan, INC. | $13.26 | 2019 | |
| Duchesnay USA Incorporated | $12.14 | 2019 | |
| Amag Pharmaceuticals, INC. | $11.27 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Britta Buchenroth listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.